Hyundai BioLand Co Ltd
KOSDAQ:052260
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hindustan Foods Ltd
NSE:HNDFDS
|
IN |
Hyundai BioLand Co Ltd
Other Assets
Hyundai BioLand Co Ltd
Other Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
Hyundai BioLand Co Ltd
KOSDAQ:052260
|
Other Assets
₩1.7B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
AmorePacific Corp
KRX:090430
|
Other Assets
₩790.6B
|
CAGR 3-Years
95%
|
CAGR 5-Years
146%
|
CAGR 10-Years
40%
|
|
|
Amorepacific Group
KRX:002790
|
Other Assets
₩1.3T
|
CAGR 3-Years
29%
|
CAGR 5-Years
20%
|
CAGR 10-Years
9%
|
|
|
Cosmax Inc
KRX:192820
|
Other Assets
₩40.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
51%
|
|
|
LG H&H Co Ltd
KRX:051900
|
Other Assets
₩729.9B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
0%
|
|
|
Kolmar Korea Co Ltd
KRX:161890
|
Other Assets
₩1.1T
|
CAGR 3-Years
-1%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
Hyundai BioLand Co Ltd
Glance View
HYUNDAI BIOLAND Co., Ltd. engages in the manufacture and sale of pharmaceutical and functional products. The company is headquartered in Cheongju, Chungcheongbuk-Do. The company went IPO on 2001-05-17. The firm operates its business through four segments. The Cosmetic Raw Material segment produces products such as portulaca extracts, ulmus extracts, crinum extracts, hyaluronic acids and arbutins. The Pharmaceutical Ingredient segment manufactures and sells products such as phellodendron extracts, ampelopsis extracts and gardenia extracts and others. The Ingredients for Health Functional Food segment produces and distributes red ginseng extract powders, seaweed powders, glucosamine powders, black garlic extract powders, dandelion extract powders, green tea extracts and others. The Medical Device segment involves in the provision of medical equipment such as tissue engineering products, comprised of biological wound dressings and collagen, as well as diagnostic kits, comprised of rapid kits, serological kits and mask packs.
See Also
What is Hyundai BioLand Co Ltd's Other Assets?
Other Assets
1.7B
KRW
Based on the financial report for Dec 31, 2025, Hyundai BioLand Co Ltd's Other Assets amounts to 1.7B KRW.
What is Hyundai BioLand Co Ltd's Other Assets growth rate?
Other Assets CAGR 5Y
0%
Over the last year, the Other Assets growth was 0%.
